Respiratory
Boehringer Ingelheim has over 90 years of heritage in managing respiratory disease. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
A Comprehensive Look at COPD Treatment Strategies: Rethinking Inhaled Corticosteroids
17/07/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104932
RELATED CONTENT
23:03
Unveiling the True Cost of COPD
21:02
The Power of Personalization with Inhaler Devices
13:01
